Literature DB >> 1924562

Nonsurgical repair of perinasal skin defects.

G D Becker1, L A Adams, B C Levin.   

Abstract

Immediate reconstruction of full-thickness skin defects after cancer surgery is a commonly accepted surgical principle used to preserve function and minimize cosmetic deformity. Healing by secondary intention, however, offers the advantages of optimal cancer surveillance, simplified wound management, and avoidance of reconstructive procedures with their associated costs and potential complications. Accurate prediction of the course of wound healing, and thereby the final functional and cosmetic result, would allow a rational approach to selection of patients for surgical or nonsurgical repair. We observed 282 patients with full-thickness perinasal (glabella, medial canthus, dorsum, sidewall, tip, ala, philtrum, alar base, and nasolabial fold) skin defects after Mohs' surgery and documented a variety of parameters affecting wound healing, including location, depth, and size of the wound. Patients were examined at intervals, and a final determination regarding cosmesis and function was made at 6 months or later. We conclude that the most important considerations in predicting the final functional and cosmetic result include location by subunit, followed by size and depth of the wound.

Entities:  

Mesh:

Year:  1991        PMID: 1924562

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  3 in total

Review 1.  [Secondary healing of the face].

Authors:  G Sebastian; A Herrmann
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

2.  [Healing by secondary intention after skin cancer surgery on the head and neck].

Authors:  F G Bechara
Journal:  Hautarzt       Date:  2013-08       Impact factor: 0.751

3.  Secondary Intention Healing of Nasal Ala and Tip Defects: A Simple and Valuable Treatment Option.

Authors:  Guangdong Wen; Dandan Mao; Mengyi Zhu; Jian Hu; Xueyan Yao; Jianzhong Zhang
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.